Obatoclax (OBX), a molecule inhibiting Mcl-1, Bcl-2 and Bcl-Xl has shown potent activity against cytogenetically distinct MM cell lines and patient cells alone or in combination with other agents [9, 15]. Here, BCL2 is linked to Miyoshi myopathy.